Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Haskell

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Nature|January 28, 2026
Vagal blood volume receptors compensate for haemorrhage and posture changeZhikai Liu, Shan Lu, Isabela A Haskell, et al.
The Journal of Clinical Investigation|September 7, 2001
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejectionC A Haskell, W W Hancock, D J Salant, et al.
Journal of Neuroimmunology|August 12, 2009
Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosisEric Blasko, Christopher A Haskell, Stewart Leung, et al.
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.
Nature Materials|September 5, 2006
Origin of defect-insensitive emission probability in In-containing (Al,In,Ga)N alloy semiconductorsShigefusa F Chichibu, Akira Uedono, Takeyoshi Onuma, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Nature|January 28, 2026
Vagal blood volume receptors compensate for haemorrhage and posture changeZhikai Liu, Shan Lu, Isabela A Haskell, et al.
The Journal of Clinical Investigation|September 7, 2001
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejectionC A Haskell, W W Hancock, D J Salant, et al.
Journal of Neuroimmunology|August 12, 2009
Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosisEric Blasko, Christopher A Haskell, Stewart Leung, et al.
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.
Nature Materials|September 5, 2006
Origin of defect-insensitive emission probability in In-containing (Al,In,Ga)N alloy semiconductorsShigefusa F Chichibu, Akira Uedono, Takeyoshi Onuma, et al.
Pageof 4